Biohaven Pharmaceutical Holding Co. Ltd.
www.biohavenpharma.com
Latest From Biohaven Pharmaceutical Holding Co. Ltd.
Newron Not Seeing Sarizotan STARS Yet
The Italian firm has some talking to do with the US FDA before it can unblind Phase III data on sarizotan, its Rett syndrome therapy which could be "potentially transformative" for Newron.
Priority Review Vouchers Post Lower Average Approval Times Than Priority NMEs
US FDA’s priority review voucher program delivers for most sponsors, a Pink Sheet analysis finds; PRVs reliably produce faster approval than priority-reviewed new drugs overall.
Lilly Expands Migraine Franchise With Reyvow Approval
Reyvow gives Lilly a second MOA in migraine, following the anti-CGRP biologic Emgality, and adds an acute therapy to the preventive agent approved in 2018.
Biopharma Quarterly Dealmaking Statistics, Q2 2019
Biopharma companies raised $12.4bn in Q2, largely from follow-on public offerings. In the latest mega-merger of the year, AbbVie spent $63bn on Allergan and its established portfolio. Many of the higher-valued alliances focused on the area of protein degradation.
Company Information
- Industry
-
Biotechnology
- Large Molecule
- Pharmaceuticals
- Therapeutic Areas
- Neurology, Nervous System
- Alias(es)
- Biohaven Pharmaceuticals
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Biohaven Pharmaceutical Holding Co. Ltd.
- Senior Management
-
Vlad Coric, MD, CEO
Jim Engelhart, CFO
Robert Berman, MD, CMO
John Tilton, Chief Commercial Officer
Charlie Conway, PhD, CSO
Elyse Stock, MD, Chief, Portfolio Strategy & Dev.
Donnie McGrath, MD, Chief, Corp. Strategy & Bus. Dev.
Kim Gentile, VP, Operations - Contact Info
-
Biohaven Pharmaceutical Holding Co. Ltd.
Phone: (203) 404-0410
234 Church St.
New Haven, CT 06510
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice